Published December 2015 | Version Accepted Version
Journal Article Open

Sugar-Dependent Modulation of Neuronal Development, Regeneration, and Plasticity by Chondroitin Sulfate Proteoglycans

Abstract

Chondroitin sulfate proteoglycans (CSPGs) play important roles in the developing and mature nervous system, where they guide axons, maintain stable connections, restrict synaptic plasticity, and prevent axon regeneration following CNS injury. The chondroitin sulfate glycosaminoglycan (CS GAG) chains that decorate CSPGs are essential for their functions. Through these sugar chains, CSPGs are able to bind and regulate the activity of a diverse range of proteins. CSPGs have been found both to promote and inhibit neuronal growth. They can promote neurite outgrowth by binding to various growth factors such as midkine (MK), pleiotrophin (PTN), brain-derived neurotrophic factor (BDNF) and other neurotrophin family members. CSPGs can also inhibit neuronal growth and limit plasticity by interacting with transmembrane receptors such as protein tyrosine phosphatase σ (PTPσ), leukocyte common antigen-related (LAR) receptor protein tyrosine phosphatase, and the Nogo receptors 1 and 3 (NgR1 and NgR3). These CS-protein interactions depend on specific sulfation patterns within the CS GAG chains, and accordingly, particular CS sulfation motifs are upregulated during development, in the mature nervous system, and in response to CNS injury. Thus, spatiotemporal regulation of CS GAG biosynthesis may provide an important mechanism to control the functions of CSPGs and to modulate intracellular signaling pathways. Here, we will discuss these sulfation-dependent processes and highlight how the CS sugars on CSPGs contribute to neuronal growth, axon guidance, and plasticity in the nervous system.

Additional Information

© 2015 Elsevier. Received 21 June 2015, Revised 14 August 2015, Accepted 19 August 2015, Available online 24 August 2015. L.C. H-W. was supported by NIH grant R01 GM093627 and the Christopher & Dana Reeve Foundation; G.M.M. was supported by NIH training grant NRSAT32GM07616.

Attached Files

Accepted Version - nihms723591.pdf

Files

nihms723591.pdf

Files (484.6 kB)

Name Size Download all
md5:693d609853dd320686efc67611d5d503
484.6 kB Preview Download

Additional details

Identifiers

PMCID
PMC4679498
Eprint ID
60090
DOI
10.1016/j.expneurol.2015.08.015
Resolver ID
CaltechAUTHORS:20150908-073103744

Funding

NIH
R01 GM093627
Christopher and Dana Reeve Foundation
NIH Predoctoral Fellowship
NRSAT32GM07616

Dates

Created
2015-09-10
Created from EPrint's datestamp field
Updated
2022-06-01
Created from EPrint's last_modified field